These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Pharmacokinetic properties of a new sustained-release theophylline preparation.
    Author: Dahlqvist R, Billing B.
    Journal: Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):69-72. PubMed ID: 6840927.
    Abstract:
    A newly developed compressed theophylline tablet with slow in vitro dissolution rate was investigated in six healthy volunteers. The mean bioavailability of theophylline during a single oral dose was 97%, which did not significantly differ from the i.v. reference. The bioavailability of Teovent-SR measured during a dosing interval at steady state was on the average 110%, significantly (p less than 0.05) higher than the i.v. standard. This points to the possibility of a lower total clearance under conditions of multiple dosing of theophylline. Thus a single i.v. dose may not be the proper reference for evaluating bioavailability of theophylline during steady state. During maintenance administration of the tablet every 12 h the maximum plasma level of theophylline was reached after 4 h. The maximum concentration during a dosage interval at steady state was on the average 22% (range 14-32) higher than the mean concentration, whereas the trough level was on the average 28% (range 20-43) below the mean. During 8.5 h, i.e., 70% of the 12 h dosing interval, at least 75% of the maximum concentration was maintained. This theophylline formulation has a complete bioavailability and slow-release characteristics that produce reasonably stable plasma concentrations over a dosing interval of 8-12 h.
    [Abstract] [Full Text] [Related] [New Search]